Showing results (21-30 of 257) with videos related to

Sort By:
Pageof 26
World Journal of Clinical Oncology|August 22, 2020
Circulating cell-free nucleic acids as prognostic and therapy predictive tools for metastatic castrate-resistant prostate cancerNavid Sobhani, Marianna Sirico, Daniele Generali, et al.
Current Pharmaceutical Design|December 1, 2017
Curcumin as an Adjunct Therapy and microRNA Modulator in Breast CancerSaeed Norouzi, Muhammed Majeed, Matteo Pirro, et al.
World Journal of Clinical Oncology|April 14, 2018
Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives?Navid Sobhani, Daniele Generali, Fabrizio Zanconati, et al.
World Journal of Clinical Oncology|January 10, 2019
Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancerNavid Sobhani, Daniele Generali, Fabrizio Zanconati, et al.
Cancers|September 14, 2024
Future AI Will Most Likely Predict Antibody-Drug Conjugate Response in Oncology: A Review and Expert OpinionNavid Sobhani, Alberto D'Angelo, Matteo Pittacolo, et al.
Cancer Biology & Therapy|July 15, 2016
Role of targeted agents in neuroendocrine tumors: Results from a meta-analysisGiandomenico Roviello, Laura Zanotti, Sergio Venturini, et al.
Investigational New Drugs|August 8, 2018
Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancerNavid Sobhani, Daniele Generali, Alberto D'Angelo, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 23, 2014
Diagnostic tests based on gene expression profile in breast cancer: from background to clinical useLaura Zanotti, Alberto Bottini, Camillo Rossi, et al.
Journal of the National Cancer Institute. Monographs|November 2, 2011
Positron emission tomography and neoadjuvant therapy of breast cancerAlexandre Cochet, Daniele Generali, Stephen B Fox, et al.
Pageof 26